It is truly ironic that the sad emergence of COVID-19 has transformed the drug and biotech companies from being the bad guys (black hats) to the good guys as we try to contain and defeat this scurrilous, worldwide epidemic. It proves the fundamental raison d’être for these companies, namely, to improve the quality and longevity of life.
